794 related articles for article (PubMed ID: 15800227)
1. Sirolimus for Kaposi's sarcoma in renal-transplant recipients.
Stallone G; Schena A; Infante B; Di Paolo S; Loverre A; Maggio G; Ranieri E; Gesualdo L; Schena FP; Grandaliano G
N Engl J Med; 2005 Mar; 352(13):1317-23. PubMed ID: 15800227
[TBL] [Abstract][Full Text] [Related]
2. Regression of Kaposi's sarcoma in renal graft recipients after conversion to sirolimus treatment.
Zmonarski SC; Boratyńska M; Rabczyński J; Kazimierczak K; Klinger M
Transplant Proc; 2005 Mar; 37(2):964-6. PubMed ID: 15848592
[TBL] [Abstract][Full Text] [Related]
3. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".
Volkow P; Zinser JW; Correa-Rotter R
BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117
[TBL] [Abstract][Full Text] [Related]
4. A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient.
Yilmaz R; Akoglu H; Kirkpantur A; Kilickap S; Arici M; Altun B; Aki T; Erdem Y; Yasavul U; Turgan C
Ren Fail; 2007; 29(1):103-5. PubMed ID: 17365918
[TBL] [Abstract][Full Text] [Related]
5. Sirolimus-induced signaling modifications in Kaposi's sarcoma with resolution in a liver transplant recipient.
Ho CM; Huang SF; Hu RH; Ho MC; Wu YM; Lee PH
Clin Transplant; 2010; 24(1):127-32. PubMed ID: 19919613
[TBL] [Abstract][Full Text] [Related]
6. Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma.
Di Paolo S; Teutonico A; Ranieri E; Gesualdo L; Schena PF
Am J Kidney Dis; 2007 Mar; 49(3):462-70. PubMed ID: 17336708
[TBL] [Abstract][Full Text] [Related]
7. Leflunomide with low-dose everolimus for treatment of Kaposi's sarcoma in a renal allograft recipient.
Basu G; Mohapatra A; Manipadam MT; Mani SE; John GT
Nephrol Dial Transplant; 2011 Oct; 26(10):3412-5. PubMed ID: 21775763
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors.
Campistol JM; Schena FP
Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i17-22. PubMed ID: 17456614
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression.
Stallone G; Infante B; Grandaliano G; Schena FP; Gesualdo L
Transpl Int; 2008 Sep; 21(9):825-32. PubMed ID: 18498314
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma after renal transplantation.
Kanitakis J
N Engl J Med; 2005 Aug; 353(8):846-7; author reply 846-7. PubMed ID: 16120869
[No Abstract] [Full Text] [Related]
11. Successful treatment of a child having generalized Kaposi's sarcoma after living donor liver transplantation with conversion to sirolimus.
Yuksekkaya HA; Arikan C; Yazici A; Baran M; Aydogdu S; Kilic M
Pediatr Transplant; 2009 May; 13(3):375-8. PubMed ID: 18452496
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus for visceral and cutaneous Kaposi's sarcoma in a renal-transplant recipient.
Gheith O; Bakr A; Wafa E; Fouda A; El Agroudy A; Refaie A; Donia A; Sabry A; Sobh M; Shokeir A; Ghoneim M
Clin Exp Nephrol; 2007 Sep; 11(3):251-254. PubMed ID: 17891357
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin for Kaposi's sarcoma and graft-versus-host disease in bone marrow transplant recipient.
Marco de F; Infante B; Giovanni S; Gesualdo L
Transplantation; 2010 Mar; 89(5):633-4. PubMed ID: 20216371
[No Abstract] [Full Text] [Related]
14. Regression of post-transplant Kaposi's sarcoma using sirolimus.
Kolhe N; Mamode N; Van der Walt J; Pattison J
Int J Clin Pract; 2006 Nov; 60(11):1509-12. PubMed ID: 16787440
[TBL] [Abstract][Full Text] [Related]
15. Complete regression of visceral Kaposi's sarcoma after conversion to sirolimus.
Mohsin N; Budruddin M; Pakkyara A; Darweesh A; Nayyer M; Amitabh J; Daar AS
Exp Clin Transplant; 2005 Dec; 3(2):366-9. PubMed ID: 16417445
[TBL] [Abstract][Full Text] [Related]
16. Posttransplant Kaposi's sarcoma restricted to the site of a previous deep venous thrombosis: abrupt onset after withdrawal of sirolimus.
González-López MA; Rodrigo E; González-Vela MC; Fernández-Llaca H; Arias-Rodríguez MA; Val-Bernal JF
Dermatology; 2006; 213(1):30-3. PubMed ID: 16778423
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus and regression of Kaposi's sarcoma in immunosuppressed transplant patient.
Pranteda G; Feliziani G; Grimaldi M; Paleologo G; Pranteda G; Melotti F; Camplone G
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1022-3. PubMed ID: 18194240
[No Abstract] [Full Text] [Related]
18. Sirolimus for Kaposi's sarcoma.
Wasywich CA; Croxson MC; van Doornum GJ; Coverdale HA; Ruygrok PN
J Heart Lung Transplant; 2006 Jun; 25(6):726-9. PubMed ID: 16730579
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of conversion to sirolimus in posttransplantation Kaposi's sarcoma.
Gutiérrez-Dalmau A; Sánchez-Fructuoso A; Sanz-Guajardo A; Mazuecos A; Franco A; Rial MC; Iranzo P; Torregrosa JV; Oppenheimer F; Campistol JM
Transplant Proc; 2005 Nov; 37(9):3836-8. PubMed ID: 16386556
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France.
Farge D
Eur J Med; 1993; 2(6):339-43. PubMed ID: 8252179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]